Aurinia Pharmaceuticals Inc (AUPH) stock forecast — our track record
7 completed AUPH stock predictions — wins and misses, nothing deleted. Each forecast was published before the outcome was known.
How our AUPH forecasts have done
Lyra published 5 AUPH stock forecasts from July 11, 2025 through the window ending February 2, 2026. Each prediction was published before the outcome was known, then closed and scored after the result was available. All 5 forecasts used the short term (0 to 3 months) horizon. There were no medium term or long term forecasts in this record.
Overall, 4 predictions reached their target. There were no misses, and 1 call was partial. The average success score was 90%. The short term calls also averaged 90%, because every published forecast for AUPH used that horizon. The average peak gain was 32.1%. The results were mostly target hits, with one positive call that did not reach its target.
The best call was published on July 11, 2025. It predicted 38% growth, and the stock rose as much as 51.6%. It reached the target in 35 days and scored 100%. The weakest call was published on November 4, 2025. It predicted 22% growth, and the stock rose as much as 4.1%. It scored 50%. The track record was strong overall, with most calls reaching their target and no full misses.
Written from the closed signals below; refreshed when new signals close.
Closed AUPH signals
| Closed | Timeframe | Predicted | Peak result | Outcome | Days to target | |
|---|---|---|---|---|---|---|
| June 29, 2026 | ||||||
| June 21, 2026 | ||||||
| February 2, 2026 | ||||||
| January 29, 2026 | ||||||
| December 7, 2025 | ||||||
| December 1, 2025 | ||||||
| October 9, 2025 |
Peak result is the highest point inside the signal’s measurement window — labelled as peak because it is not a realized return.
See what we’re calling today.
Every published signal is scored against what the stock actually did — the same way AUPH was. No deleted misses, no cherry-picking.